Electroceuticals/Bioelectric Medicine Market

Medtronic plc (Ireland) and Abbott Laboratories, Inc. (US) are Leading Players in the Electroceuticals/Bioelectric Medicine Market

The global electroceuticals/bioelectric medicine market is projected to reach USD 21.5 billion by 2026 from USD 16.8 billion in 2021, at a CAGR of 5.0% during the forecast period. Growth in the electroceuticals market is mainly driven by factors such as the rising geriatric population and subsequent growth in the prevalence of neurological & cardiovascular disorders, rising government support & funding for neurological disorders, and the increasing investments and funding for research on CRM devices. However, the high cost of electroceutical devices and the requirement of high capital investments are the major factors hampering the growth of this market.

The major players in this market are Medtronic plc (Ireland), Boston Scientific Corporation (US), Abbott Laboratories, Inc. (US), LivaNova PLC (UK), Cochlear Ltd. (Australia), MicroPort Scientific Corporation (China), Sonova Group (Switzerland), Nevro Corp. (US), Axonics Modulation Technologies, Inc. (US), Neuronetics, Inc. (US), Second Sight Medical Products, Inc. (US), NeuroPace, Inc. (US), BIOTRONIK (Germany), Medico S.p.A. (Italy), Nurotron Biotechnology Co. Ltd. (US), MED-EL (Austria), Aleva Neurotherapeutics SA (Switzerland), NeuroSigma, Inc. (US), BioWave Corporation (US), Soterix Medical Inc. (US), Bioinduction Ltd. (UK), GiMer Medical (Taiwan), Cefaly (Belgium), BioControl Medical (Israel), and tVNS Technologies GmbH (Germany).

To know about the assumptions considered for the study download the pdf brochure

In 2020, Medtronic plc held the leading position in the electroceuticals/bioelectric medicine market. The company has maintained a leading position in the market through its strong distribution networks across North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The company adopts organic growth strategies to increase its dominance in this market. For instance, in August 2020, the company launched its InterStim Micro Neurostimulator in the US. Additionally, in January 2020, the company received CE approval for its InterStim Micro Neurostimulator in Europe. Such developments have helped the company significantly expand its product line and enhance its visibility in the electroceuticals/bioelectric medicine market. The company intends to partner with new businesses to complement its existing business segments. Such developments will enable Medtronic plc to add innovative technologies and products to its portfolio, which, in turn, will strengthen its presence in the electroceuticals/bioelectric medicine market.

In 2020, Abbott Laboratories, Inc. accounted for the second-largest share of the electroceuticals/bioelectric medicine market. The company’s leading position in this market can be attributed to its strong sales and distribution network globally, enabling it to market its products in various countries effectively. In addition, Abbott Laboratories, Inc. invests a significant amount of its revenue on R&D. This enables the company to develop and launch new products in the market. In January 2020, the company received approval from the US FDA for a new expanded indication for its Infinity Deep Brain Stimulation (DBS) system to treat Parkinson’s disease. Additionally, in September 2019, the company received US FDA approval for its Proclaim XR Recharge-free neurostimulation system. Such developments have strengthened the company’s position in the electroceuticals/bioelectric medicine market.

Boston Scientific Corporation’s leading position in this market can be attributed to its strong sales and distribution network across the globe, which enables it to effectively market its products in various countries.  To sustain its leading position in the market, the company pursues inorganic growth strategies. For instance, in May 2019, the company acquired Vertiflex, Inc. (US). This acquisition was focused on expanding the breadth of Boston Scientific’s pain management product portfolio. Such developments have helped the company enhance its visibility in the market.

Related Reports:

Electroceuticals/Bioelectric Medicine Market by Product (Pacemaker, ICD, Cochlear Implant, Deep Brain, Spinal Cord, Vagus, Sacral Nerve Stimulators), Application (Ischemia, Epilepsy), Type (Implantable, Noninvasive), End User - Global Forecast to 2026

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]

Report Code
MD 4358
RI Published ON
6/18/2021
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Electroceuticals/Bioelectric Medicine Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2021 MarketsandMarkets Research Private Ltd. All rights reserved